Clinical Trial: miR-101-3p and Autotaxin in SLE Patients

U.S., Nov. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07252141) titled 'miR-101-3p and Autotaxin in SLE Patients' on Nov. 19.

Brief Summary: Systemic lupus erythematosus (SLE) is a complex autoimmune disease affecting multiple organs and characterized by heterogeneous clinical manifestations. This case-control study aims to assess the association between serum expression levels of MicroRNA-101-3p and Autotaxin (ATX) in SLE patients compared with healthy controls. The hypothesis is that dysregulation of miR-101-3p and ATX contributes to SLE pathogenesis and may serve as potential non-invasive biomarkers for disease activity and prognosis.

Study Start Date: Dec. 30

Study Type: OBSERVATIONAL

Condition: ...